NCT07092358View on ClinicalTrials.gov

Hereditary Ataxia Research on Multi-Omics and Neuroclinical Insights in the Yangtze Delta

RecruitingOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

June 30, 2035

Study Completion Date

December 31, 2035

Conditions
Hereditary Ataxia
Interventions
OTHER

None of intervention

No specific intervention was implemented in this study.

Trial Locations (2)

200040

RECRUITING

Huashan Hospital, Fudan University, Shanghai

310009

RECRUITING

Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
collaborator

Huashan Hospital

OTHER

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

NCT07092358 - Hereditary Ataxia Research on Multi-Omics and Neuroclinical Insights in the Yangtze Delta | Biotech Hunter | Biotech Hunter